Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $785 Million - $886 Million
4,097,700 Added 72.72%
9,732,600 $2.06 Billion
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $861 Million - $947 Million
4,589,900 Added 439.22%
5,634,900 $1.08 Billion
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $133 Million - $212 Million
1,045,000 New
1,045,000 $212 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.